Related Experiment Video
Updated: Dec 20, 2025

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
1.4K
Massive transfusion protocols in paediatric trauma population: A systematic review.
Kyle Kinslow1, Mark McKenney1,2, Dessy Boneva1,2
1Department of Surgery, Kendall Regional Medical Center, Miami, Florida, USA.
Transfusion Medicine (Oxford, England)
|May 25, 2020
Summary
Paediatric massive transfusion (PMT) protocols lack a clear definition and optimal blood product ratios. While PMT implementation shows benefits in reducing transfusion times, evidence for improved paediatric trauma mortality remains limited, though morbidity may decrease.
Area of Science:
- Pediatric Emergency Medicine
- Trauma Resuscitation
- Blood Transfusion Practices
Background:
- Paediatric massive transfusion (PMT) protocols are critical in managing severe hemorrhage in children.
- Existing literature lacks consensus on PMT definition, optimal blood product ratios, and overall outcomes.
Purpose of the Study:
- To review the literature and define paediatric massive transfusion (PMT).
- To identify investigated blood product ratios and their impact on paediatric outcomes.
- To evaluate existing evidence on PMT outcomes in children.
Main Methods:
- Systematic literature review following PRISMA guidelines.
- Searched multiple databases including PubMed, Google Scholar, and EMBASE.
- Included articles were assessed for study design, PMT definition, activation criteria, and transfusion ratios.
Main Results:
- 33 articles were included from 3213 initial searches.
- PMT definitions vary, primarily based on volume/kg but with differing timeframes.
- Some studies suggest improved paediatric mortality with balanced transfusion ratios (1:1 FFP:pRBC), but evidence is limited. PMT implementation did not consistently reduce paediatric trauma mortality but improved operational aspects like time to first transfusion.
Conclusions:
- A clear consensus on PMT definition is lacking; early recognition definitions show promise.
- Evidence for an optimal blood product ratio in PMT is insufficient, though balanced ratios appear favorable.
- PMT protocols have not consistently improved paediatric trauma mortality but may reduce morbidity and improve transfusion timeliness.
Related Concept Videos
Blood Transfusion and Agglutination
13.9K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
13.9K
Blood Transfusion
2.0K
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
2.0K
Bone Marrow Sampling and Transplants
728
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
728

